Tumor Burden Affects Efficacy of Combination Immunotherapy

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2019-021
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Early Use of Steroids Affects Immune Cells and Impairs Immunotherapy Efficacy

ESMO Open
Cancer ResearchOncology
2019English

Tumor Neoantigen Heterogeneity Thresholds Provide a Time Window for Combination Immunotherapy

2019English

A Mathematical Model of the Enhancement of Tumor Vaccine Efficacy by Immunotherapy

Bulletin of Mathematical Biology
GeneticsPharmacologyMolecular BiologyEnvironmental ScienceBiochemistryBiological SciencesMathematicsImmunologyComputational TheoryAgriculturalNeuroscience
2012English

Combination Immunotherapy for Melanoma

JAMA Oncology
Cancer ResearchOncology
2015English

MS21.06 Immunotherapy - Sequence or Combination?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

New Perspective on Targeting the Tumor Suppressor P53 Pathway in the Tumor Microenvironment to Enhance the Efficacy of Immunotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Tumor Mutational Burden Determined by Panel Sequencing Predicts Survival After Immunotherapy in Patients With Advanced Gastric Cancer

Frontiers in Oncology
Cancer ResearchOncology
2020English

Abdominal Sepsis: Efficacy of Passive Immunotherapy

Critical Care
Critical CareIntensive Care Medicine
2007English

Efficacy of Specific Immunotherapy of Abdominal Sepsis

Critical Care
Critical CareIntensive Care Medicine
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy